Medicazone Super Specialty Hospital & Research Center Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.10 Cr
as on 01-01-2025
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 11.34%
(FY 2023)
About Medicazone Super Specialty Hospital & Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.10 Cr.
Satish Das, Sanket Dube, and Sachin Bhandekar serve as directors at the Company.
- CIN/LLPIN
U85110MH2021PTC366461
- Company No.
366461
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medicazone Super Specialty Hospital & Research Center?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Das  | Director | 28-Aug-2021 | Current |
| Sanket Dube | Director | 28-Aug-2021 | Current |
| Sachin Bhandekar | Director | 28-Aug-2021 | Current |
Financial Performance of Medicazone Super Specialty Hospital & Research Center.
Medicazone Super Specialty Hospital & Research Center Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medicazone Super Specialty Hospital & Research Center?
Unlock access to Medicazone Super Specialty Hospital & Research Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Sep 2024 | ₹3.00 Cr | Open |
Others Creation Date: 09 Nov 2021 | ₹2.10 Cr | Open |
How Many Employees Work at Medicazone Super Specialty Hospital & Research Center?
Medicazone Super Specialty Hospital & Research Center has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicazone Super Specialty Hospital & Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicazone Super Specialty Hospital & Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
